On the other hand, compared to DCM + AAV9-NC + PPARα agonist group mice, DCM + AAV9-GDF11 + PPARα agonist group mice had reduced myocardial fibrosis (Fig. 6C). This evidence concerns the gene GDF11 and familial dilated cardiomyopathy.